OCC 1.61% 63.0¢ orthocell limited

Ann: Striate US Market Entry Update, page-26

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,867 Posts.
    lightbulb Created with Sketch. 7107
    YOu've changed your sentiment sharply. Its understandable, its been a long and miserable ride in most bio-techs in the last two years, rising less than the rest of the market on the Fed bubble and falling more than the general mkt since.

    2022 could be a very different year:

    https://www.fiercebiotech.com/biotech/biopharma-ma-2022-different-animal-drugmakers-coffers-lined-17t

    If OCC does not get some partnerships going I'd be very surprised in that context. I expect continued M&A in the CAR-T cell space, but plenty of spill over...
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
63.0¢
Change
0.010(1.61%)
Mkt cap ! $150.6M
Open High Low Value Volume
63.5¢ 65.0¢ 63.0¢ $298.9K 469.1K

Buyers (Bids)

No. Vol. Price($)
2 19131 63.0¢
 

Sellers (Offers)

Price($) Vol. No.
64.0¢ 24050 3
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.